Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

2.820

+0.020 (0.71%)

May 9, 2025, 11:03 AM - Market open

Grace Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	May '25 May 9, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2015 - 2019
Market Capitalization	39	32	21	54	120	34	Upgrade
Market Cap Growth	39.61%	56.90%	-62.03%	-55.00%	250.73%	-57.04%	Upgrade
Enterprise Value	27	7	-10	8	92	16	Upgrade
Last Close Price	2.80	3.42	2.76	7.32	28.80	18.22	Upgrade
Debt / Equity Ratio	-	-	0.01	0.00	0.00	0.01	Upgrade
Asset Turnover	-	-	-	-	0.01	-	Upgrade
Quick Ratio	5.76	14.09	8.41	13.56	38.80	2.00	Upgrade
Current Ratio	6.06	14.26	8.59	13.89	39.50	2.50	Upgrade
Return on Equity (ROE)	-22.89%	-19.82%	-48.15%	-11.98%	-57.33%	-212.26%	Upgrade
Return on Assets (ROA)	-15.16%	-9.25%	-10.96%	-7.94%	-15.70%	-51.13%	Upgrade
Return on Capital (ROIC)	-17.83%	-10.83%	-12.86%	-9.23%	-19.45%	-119.57%	Upgrade
Buyback Yield / Dilution	-34.86%	-28.16%	-21.09%	-148.46%	-40.25%	-55.79%	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q